Associate Professor Massachusetts General Hospital Boston, MA, United States
Disclosure(s):
Elaine W. Yu, MD: Abbvie: Consultant (); Amgen Inc.: Contracted Research (Principal Investigators must provide information, even if received by the institution) (); Wolters Kluwer: Royalties ()
This session characterizes the effects of different methods of weight loss (i.e. caloric restriction, metabolic and bariatric surgery (MBS), and glucagon-like peptide-1 receptor agonists (GLP-1Ra) on musculoskeletal health in people living with obesity (PwO) and summarizes current management approaches including lifestyle and pharmacological treatments
